AB Science, Ales, Bastide, Naturex : French Equity Preview

The following companies’ shares may be active in Paris. Symbols are in parentheses after company names and prices are from the last close.

France’s CAC 40 Index fell 20.55, or 0.7 percent, to 3,119. The SBF 120 Index (SBF120) declined 0.5 percent.

AB Science SA (AB) : The French drugmaker plans to sell 7.5 million euros ($10.8 million) of convertible bonds. The bonds will pay interest of 1.25 percent and are convertible into stock at a price of 12.65 euros a share. The shares gained 15 percent to 7.85 euros.

Ales Groupe (ALPHY) : The maker of Laboratoires Lierac cosmetics said second-quarter revenue rose to 52.4 million euros from 43.5 million euros. The shares rose 1.4 percent to 12.43 euros.

Avenir Telecom (AVT) SA: The distributor of mobile telecommunications equipment said first-quarter revenue fell to 103.2 million euros from 129 million euros. The shares fell 1.4 percent to 71 euro cents.

Bastide le Confort Médical (BLC FP): The provider of home health-care services said full-year revenue rose 9.2 percent to 109.1 million euros. The shares fell 0.4 percent to 7.70 euros.

Naturex (NRX) : The producer of natural vegetable ingredients and extracts said first-half net income rose to 9.7 million euros from 7.6 million euros. The stock rose 0.5 percent to 53.58 euros.

To contact the reporter on this story: Alan Katz in Paris at akatz5@bloomberg.net.

To contact the editor responsible for this story: Melissa Pozsgay at mpozsgay@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.